[{"caption":"Table 2 Evaluation results of Text-to-UMLS linking on validation and testing data from MIMIC-III discharge summaries \n\nvalidation (n\u003d142+/400) \ntest (n\u003d187+/673) \ntest, seen in WS (n\u003d80+/499) \ni.e. both rules [not] satisfied \n\ntest, unseen in WS (n\u003d107+/174) \ni.e. only one rule satisfied \nText to UMLS \nP \nR \nF1 \nP \nR \nF1 \nP \nR \nF1 \nP \nR \nF1 \nGHNL API [21] \n78.9 \n81.7 \n80.3 \n75.3 \n78.1 \n76.6 \n54.3 \n62.5 \n58.1 \n94.1 \n89.7 \n91.9 \nMedCAT [22] \n83.3 \n91.5 \n87.2 \n70.3 \n87.2 \n77.8 \n56.6 \n75.0 \n64.5 \n81.7 \n96.3 \n88.4 \nSemEHR [15] \n35.5 \n100.0 \n52.4 \n27.8 \n100.0 \n43.5 \n16.0 \n100.0 \n27.6 \n61.5 \n100.0 \n76.2 \n+ rules \n80.9 \n89.4 \n84.9 \n68.6 \n94.7 \n79.6 \n83.3 \n87.5 \n85.4 \n61.5 \n100.0 \n76.2 \n+ WS (rules+BERT) \n92.0 \n89.4 \n90.7 \n81.4 \n91.4 \n86.1 \n83.3 \n87.5 \n85.4 \n80.2 \n94.4 \n86.7 \n+ SS (anns+BERT) \n-\n-\n-\n88.4 \n93.6 \n90.9 \n87.7 \n88.8 \n88.2 \n88.9 \n97.2 \n92.9 \n","rows":["+ WS ( rules+BERT )","+ SS ( anns+BERT )","MedCAT [ 22 ]","SemEHR [ 15 ]","+ rules","GHNL API [ 21 ]","-"],"columns":["P","i . e . only one rule satisfied","R","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test ( n\u003d187+ / 673 )","F1","test , unseen in WS ( n\u003d107+ / 174 )","i . e . both rules [ not ] satisfied"],"mergedAllColumns":[],"numberCells":[{"number":"77.8","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"58.1","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"89.7","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"87.5","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"16.0","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"89.4","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"88.9","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"43.5","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"88.4","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"76.2","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"90.7","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"78.9","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"80.2","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"92.0","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"88.8","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"83.3","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"70.3","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"81.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"94.4","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"90.9","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"62.5","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"88.4","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"87.2","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"54.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"100.0","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"85.4","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"61.5","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"76.6","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"91.5","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"27.8","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"84.9","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"79.6","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"85.4","isBolded":true,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"76.2","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"64.5","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"86.1","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"81.7","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"27.6","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"80.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"94.1","isBolded":true,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"75.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"56.6","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"61.5","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","P"],"associatedMergedColumns":[]},{"number":"86.7","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"97.2","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"96.3","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"94.7","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"81.4","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"100.0","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"87.7","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"75.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"89.4","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"100.0","isBolded":true,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"87.2","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"100.0","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","R"],"associatedMergedColumns":[]},{"number":"93.6","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"88.2","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"91.9","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"52.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","F1"],"associatedMergedColumns":[]},{"number":"100.0","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"83.3","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"78.1","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"87.5","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"92.9","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , unseen in WS ( n\u003d107+ / 174 )","test ( n\u003d187+ / 673 )","i . e . only one rule satisfied","F1"],"associatedMergedColumns":[]},{"number":"80.9","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"35.5","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","validation ( n\u003d142+ / 400 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"68.6","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]},{"number":"91.4","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","R"],"associatedMergedColumns":[]},{"number":"83.3","isBolded":true,"associatedRows":["+ rules"],"associatedColumns":["Table 2 Evaluation results of Text - to - UMLS linking on validation and testing data from MIMIC - III discharge summaries","test , seen in WS ( n\u003d80+ / 499 )","test ( n\u003d187+ / 673 )","i . e . both rules [ not ] satisfied","P"],"associatedMergedColumns":[]}]},{"caption":"Table 3 Comparison among embeddings for weakly supervised \nText-to-UMLS linking from MIMIC-III discharge summaries \n\nvalidation (n\u003d142+/400) \ntest (n\u003d187+/673) \nText to UMLS \nP \nR \nF1 \nP \nR \nF1 \nWord2Vec-100 \n86.6 \n50.0 \n63.4 \n85.1 \n61.0 \n71.0 \nWord2Vec-300 \n85.7 \n59.2 \n70.0 \n80.7 \n69.5 \n74.7 \nWord2Vec-768 \n85.1 \n68.3 \n75.8 \n78.9 \n78.1 \n78.5 \nBERT \n88.1 \n83.8 \n85.9 \n79.5 \n91.4 \n85.1 \nPubMedBERT \n88.7 \n77.5 \n82.7 \n79.6 \n87.7 \n83.5 \nSapBERT \n88.3 \n79.6 \n83.7 \n80.8 \n89.8 \n85.1 \nBlueBERT-base \n90.1 \n89.4 \n89.8 \n80.4 \n92.0 \n85.8 \n+ fine-tuning \n84.6 \n88.7 \n86.6 \n73.5 \n92.0 \n81.7 \nBlueBERT-large \n89.1 \n80.3 \n84.4 \n79.0 \n88.8 \n83.6 \n","rows":["Word2Vec - 100","PubMedBERT","SapBERT","Word2Vec - 300","Word2Vec - 768","BlueBERT - large","BlueBERT - base","BERT","+ fine - tuning"],"columns":["P","R","Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","test ( n\u003d187+ / 673 )","F1"],"mergedAllColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"],"numberCells":[{"number":"78.5","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"84.4","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"69.5","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"63.4","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"68.3","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"79.0","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"77.5","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"89.4","isBolded":true,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"82.7","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"84.6","isBolded":false,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"71.0","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"80.8","isBolded":true,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"59.2","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"50.0","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"92.0","isBolded":true,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"80.7","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"88.8","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"74.7","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"80.4","isBolded":false,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"79.5","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"78.9","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.1","isBolded":false,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"92.0","isBolded":true,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"89.1","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"83.6","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"79.6","isBolded":false,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.1","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"89.8","isBolded":true,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"83.8","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"91.4","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"80.3","isBolded":false,"associatedRows":["BlueBERT - large"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"86.6","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"88.7","isBolded":false,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"75.8","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"78.1","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"83.7","isBolded":false,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"86.6","isBolded":false,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.8","isBolded":true,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"83.5","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.9","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"87.7","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"89.8","isBolded":false,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"88.1","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"79.6","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.1","isBolded":false,"associatedRows":["Word2Vec - 768"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.7","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["Word2Vec - 300"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"88.3","isBolded":false,"associatedRows":["SapBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"88.7","isBolded":false,"associatedRows":["PubMedBERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"90.1","isBolded":true,"associatedRows":["BlueBERT - base"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","validation ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"73.5","isBolded":false,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"61.0","isBolded":false,"associatedRows":["Word2Vec - 100"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"85.1","isBolded":false,"associatedRows":["BERT"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]},{"number":"81.7","isBolded":false,"associatedRows":["+ fine - tuning"],"associatedColumns":["Table 3 Comparison among embeddings for weakly supervised","test ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["Text - to - UMLS linking from MIMIC - III discharge summaries"]}]},{"caption":"Table 4 Results on rare disease identification (Text-to-ORDO) \nfrom MIMIC-III discharge summaries \n\nvalidation (n\u003d64+/400) \ntest (n\u003d82+/673) \nText to ORDO \nP \nR \nF1 \nP \nR \nF1 \nGHNL API [21] \n47.6 \n60.9 \n53.4 \n44.2 \n51.2 \n47.5 \nMedCAT [22] \n59.6 \n82.8 \n69.3 \n48.8 \n76.8 \n59.7 \nSemEHR [15] \n18.7 \n95.3 \n31.3 \n13.9 \n92.7 \n24.1 \n+ rules \n53.9 \n75.0 \n62.7 \n49.0 \n86.6 \n62.6 \n+ WS (rules+BERT) \n67.6 \n75.0 \n71.1 \n64.7 \n80.5 \n71.7 \n+ SS (anns+BERT) \n-\n-\n-\n73.3 \n80.5 \n76.7 \nThe column statistics (n\u003dN++/N ) shows number of positive data N+ \nand all samples N in the dataset. WS, weak supervision; SS, strong su-\npervision; anns, annotations. BlueBERT-base (PubMed+MIMIC-III) was \nused as the BERT model. \n\n","rows":["+ WS ( rules+BERT )","+ SS ( anns+BERT )","MedCAT [ 22 ]","SemEHR [ 15 ]","+ rules","GHNL API [ 21 ]","-"],"columns":["P","R","test ( n\u003d82+ / 673 )","Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"mergedAllColumns":["from MIMIC - III discharge summaries"],"numberCells":[{"number":"60.9","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"71.1","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"47.5","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"18.7","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"64.7","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"48.8","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"49.0","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"82.8","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"69.3","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"53.4","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"59.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"71.7","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"47.6","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"75.0","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"95.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"75.0","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"53.9","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"51.2","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"62.6","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"13.9","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"24.1","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"67.6","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"76.8","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"86.6","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"44.2","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"31.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"62.7","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"80.5","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"59.6","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","validation ( n\u003d64+ / 400 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"92.7","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"73.3","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","P"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"80.5","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","R"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]},{"number":"76.7","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 4 Results on rare disease identification ( Text - to - ORDO )","test ( n\u003d82+ / 673 )","F1"],"associatedMergedColumns":["from MIMIC - III discharge summaries"]}]},{"caption":"Table 5 External Validation Results on Radiology Reports from \nMIMIC-III and NHS Tayside \n\nMIMIC-III Radiology \n(n\u003d53+/198) \n\nTayside Brain Imaging \n(n\u003d79+/283) \nText to UMLS \nP \nR \nF1 \nP \nR \nF1 \nSemEHR [15] \n26.7 \n100.0 \n42.2 \n26.9 \n94.9 \n41.9 \n+ WS (transfer) \n54.4 \n92.5 \n68.5 \n56.3 \n91.1 \n69.6 \n+ SS (transfer) \n89.4 \n79.2 \n84.0 \n69.0 \n62.0 \n65.3 \n+ rules (tuned) \n87.5 \n92.5 \n89.9 \n56.8 \n94.9 \n71.1 \n+ WS (in-domain) \n72.9 \n96.2 \n82.9 \n48.0 \n92.4 \n63.2 \n+ WS (+ tuning R) \n81.5 \n100.0 \n89.8 \n58.1 \n94.9 \n72.1 \n+ WS (+ tuning F1) \n89.1 \n92.5 \n90.7 \n75.3 \n88.6 \n81.4 \n\n","rows":["+ rules ( tuned )","SemEHR [ 15 ]","+ SS ( transfer )","+ WS ( in - domain )","+ WS ( transfer )","+ WS ( + tuning R )","+ WS ( + tuning F1 )"],"columns":["P","( n\u003d53+ / 198 )","R","Table 5 External Validation Results on Radiology Reports from","( n\u003d79+ / 283 )","F1","Tayside Brain Imaging","MIMIC - III Radiology"],"mergedAllColumns":["MIMIC - III and NHS Tayside"],"numberCells":[{"number":"92.5","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"88.6","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"75.3","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"92.4","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"92.5","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"90.7","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"26.7","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"79.2","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"71.1","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"63.2","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"65.3","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"89.1","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"69.6","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"69.0","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"89.9","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"100.0","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"89.8","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"62.0","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"81.5","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"87.5","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"94.9","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"56.8","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"100.0","isBolded":true,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"72.9","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"56.3","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"68.5","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"84.0","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"58.1","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"42.2","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"92.5","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"89.4","isBolded":true,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"81.4","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"26.9","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"94.9","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"82.9","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"54.4","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"72.1","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"41.9","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"94.9","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"48.0","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"96.2","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","MIMIC - III Radiology","( n\u003d53+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]},{"number":"91.1","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 5 External Validation Results on Radiology Reports from","Tayside Brain Imaging","( n\u003d79+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and NHS Tayside"]}]},{"caption":"Table 6 Statistics of Clinical Note Datasets with the Natural \nLanguage Processing Pipeline and Manual Annotations \n\nMIMIC-III Disch \nMIMIC-III Rad \nTayside Brain Img \n|T | \n59,652 \n522,279 \n156,618 \n|D| \n127,150 \n109,096 \n7,761 \n|D weak + | \n15,598 \n13,907 \n1,137 \n|D weak ? | \n74,217 \n65,171 \n2,898 \n|T RD | \n37,110 \n73,589 \n7,321 \n|T weak \nRD | \n10,568 \n21,102 \n2,855 \n|T ann | \n500 \n1,000 \n5,000 \n|D ann | \n1,073 \n198 \n279+4 \n|T ann \nRD | \n312 \n145 \n273 \n\n","rows":["|T ann","|T ann |","|D ann |","|","1 , 073"],"columns":["Table 6 Statistics of Clinical Note Datasets with the Natural","13 , 907","156 , 618","522 , 279","MIMIC - III Rad","37 , 110","Tayside Brain Img","73 , 589","1 , 000","MIMIC - III Disch","127 , 150","5 , 000","59 , 652","1 , 137","65 , 171","109 , 096","7 , 761","7 , 321","2 , 855","10 , 568","74 , 217","2 , 898","21 , 102","15 , 598"],"mergedAllColumns":["RD","279+4"],"numberCells":[{"number":"500","isBolded":false,"associatedRows":["|T ann |"],"associatedColumns":["Table 6 Statistics of Clinical Note Datasets with the Natural","MIMIC - III Disch","59 , 652","127 , 150","15 , 598","74 , 217","37 , 110","10 , 568"],"associatedMergedColumns":["RD"]},{"number":"312","isBolded":false,"associatedRows":["|T ann","|"],"associatedColumns":["Table 6 Statistics of Clinical Note Datasets with the Natural","MIMIC - III Disch","59 , 652","127 , 150","15 , 598","74 , 217","37 , 110","10 , 568","1 , 000"],"associatedMergedColumns":["279+4"]},{"number":"198","isBolded":false,"associatedRows":["|D ann |","1 , 073"],"associatedColumns":["Table 6 Statistics of Clinical Note Datasets with the Natural","MIMIC - III Rad","522 , 279","109 , 096","13 , 907","65 , 171","73 , 589","21 , 102","1 , 000"],"associatedMergedColumns":["RD"]},{"number":"145","isBolded":false,"associatedRows":["|T ann","|"],"associatedColumns":["Table 6 Statistics of Clinical Note Datasets with the Natural","MIMIC - III Rad","522 , 279","109 , 096","13 , 907","65 , 171","73 , 589","21 , 102","1 , 000"],"associatedMergedColumns":["279+4"]},{"number":"273","isBolded":false,"associatedRows":["|T ann","|"],"associatedColumns":["Table 6 Statistics of Clinical Note Datasets with the Natural","Tayside Brain Img","156 , 618","7 , 761","1 , 137","2 , 898","7 , 321","2 , 855","5 , 000"],"associatedMergedColumns":["279+4"]}]},{"caption":"Table 7 F 1 , Precision (P), and Recall (R) scores with respect to the weak rule parameters p and l in Text-to-UMLS linking for MIMIC-III \ndischarge summaries (with the highest F 1 score in bold) \n\nl \u003d 2 \nl \u003d 3 \nl \u003d 4 \nF1 \nP \nR \nF1 \nP \nR \nF1 \nP \nR \np \u003d 0.0001 \n73.7% \n64.1% \n86.6% \n59.3% \n86.5% \n45.1% \n64.3% \n87.8% \n50.7% \np \u003d 0.0005 \n73.7% \n59.6% \n96.5% \n82.6% \n91.5% \n75.4% \n79.8% \n91.0% \n71.1% \np \u003d 0.001 \n72.8% \n57.3% \n100.0% \n80.8% \n91.2% \n72.5% \n79.8% \n91.0% \n71.1% \np \u003d 0.005 \n71.5% \n55.7% \n100.0% \n89.8% \n90.1% \n89.4% \n87.5% \n91.5% \n83.8% \np \u003d 0.01 \n71.0% \n55.0% \n100.0% \n89.7% \n87.3% \n92.3% \n88.5% \n90.4% \n86.6% \np \u003d 0.05 \n63.7% \n46.7% \n100.0% \n64.0% \n47.0% \n100.0% \n64.3% \n47.3% \n100.0% \np \u003d 0.1 \n60.0% \n42.9% \n100.0% \n60.0% \n42.9% \n100.0% \n60.0% \n42.9% \n100.0% \n\n","rows":["non - M","non - M+DS","p \u003d","M","M+DS"],"columns":["P","R","Table 7 F","validation set ( n\u003d142+ / 400 )","l \u003d 2","F1","l \u003d 4","test set ( n\u003d187+ / 673 )","l \u003d 3"],"mergedAllColumns":["1 score in bold )","summaries"],"numberCells":[{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"72.7","isBolded":false,"associatedRows":["M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"86.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"50.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"68.7","isBolded":false,"associatedRows":["M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"90.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.005","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"92.0","isBolded":true,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"69.4","isBolded":false,"associatedRows":["M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"55.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.4","isBolded":true,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"59.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"62.6","isBolded":false,"associatedRows":["M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"80.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"73.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"80.4","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"71.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"79.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.1","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"86.5","isBolded":false,"associatedRows":["M"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"78.0","isBolded":false,"associatedRows":["M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"91.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.05","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"82.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"46.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"55.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"78.6","isBolded":false,"associatedRows":["M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"62.7","isBolded":false,"associatedRows":["M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"96.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"91.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"63.4","isBolded":false,"associatedRows":["M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"79.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"63.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"86.4","isBolded":false,"associatedRows":["M+DS"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"87.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"61.0","isBolded":false,"associatedRows":["M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"92.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.9","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"0.01","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"81.3","isBolded":true,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"89.9","isBolded":false,"associatedRows":["non - M"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"0.0001","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"87.3","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"59.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"72.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.8","isBolded":true,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"57.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"47.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"73.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.8%","isBolded":true,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"87.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.1","isBolded":true,"associatedRows":["non - M+DS"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"72.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"75.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.0005","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"91.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"88.6","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"73.2","isBolded":false,"associatedRows":["M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"47.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"45.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"88.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"87.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"85.9","isBolded":true,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"91.2%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"86.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"83.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"85.8","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.001","isBolded":false,"associatedRows":["non - M","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"91.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"86.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]}]},{"caption":"Table 8 Comparison among encoding strategies for weakly \nsupervised Text-to-UMLS linking on MIMIC-III discharge \nsummaries \n\nvalidation set (n\u003d142+/400) \ntest set (n\u003d187+/673) \nText to UMLS \nP \nR \nF1 \nP \nR \nF1 \nnon-M \n89.9 \n87.3 \n88.6 \n81.3 \n90.9 \n85.9 \nnon-M+DS \n90.1 \n89.4 \n89.8 \n80.4 \n92.0 \n85.8 \nM \n86.5 \n63.4 \n73.2 \n78.6 \n61.0 \n68.7 \nM+DS \n86.4 \n62.7 \n72.7 \n78.0 \n62.6 \n69.4 \nM denotes mention masking and non-M denotes no mention masking \napplied. DS denotes using document structure names. ","rows":["MedCAT [ 22 ]","+ rules","non - M+DS","GHNL API [ 21 ]","ICD","p \u003d","-","M","M+DS","+ WS ( rules+BERT )","+ SS ( anns+BERT )","ICD ? SemEHR+SS","non - M","SemEHR [ 15 ]","ICD ? SemEHR+WS"],"columns":["test","F1","( n\u003d30+ / 117 * 55 )","P","R","Table 7 F","validation set ( n\u003d142+ / 400 )","l \u003d 2","l \u003d 4","test set ( n\u003d187+ / 673 )","( n\u003d42+ / 192 * 82 )","l \u003d 3","validation"],"mergedAllColumns":["1 score in bold )","identification for MIMIC - III discharge summaries","summaries"],"numberCells":[{"number":"61.0","isBolded":false,"associatedRows":["M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"55.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"57.1","isBolded":false,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"63.4","isBolded":false,"associatedRows":["M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"91.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"54.0","isBolded":false,"associatedRows":["+ rules","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"87.3","isBolded":false,"associatedRows":["non - M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"89.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.1","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"55.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"80.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"92.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.9","isBolded":false,"associatedRows":["non - M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"91.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"87.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"40.4","isBolded":false,"associatedRows":["GHNL API [ 21 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"87.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"48.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"59.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"82.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"58.6","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.4","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"59.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"69.4","isBolded":false,"associatedRows":["M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"88.1","isBolded":false,"associatedRows":["+ rules","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"49.3","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"91.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"15.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"71.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"12.7","isBolded":false,"associatedRows":["SemEHR [ 15 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"54.8","isBolded":false,"associatedRows":["GHNL API [ 21 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"95.2","isBolded":false,"associatedRows":["SemEHR [ 15 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"38.9","isBolded":false,"associatedRows":["+ rules","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"0.01","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"90.1","isBolded":false,"associatedRows":["non - M+DS"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"75.4%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"55.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"89.9","isBolded":false,"associatedRows":["non - M"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"85.7","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"90.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.005","isBolded":false,"associatedRows":["non - M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"55.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"87.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"70.0","isBolded":false,"associatedRows":["GHNL API [ 21 ]","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"47.9","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"64.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"40.4","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"64.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"46.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"72.7","isBolded":false,"associatedRows":["M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"76.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"85.8","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"59.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"88.6","isBolded":false,"associatedRows":["non - M","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"56.2","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"50.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"62.6","isBolded":false,"associatedRows":["M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"92.0","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"78.0","isBolded":false,"associatedRows":["M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"69.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"68.7","isBolded":false,"associatedRows":["M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"68.7","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"60.6","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"91.2%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"72.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"79.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"81.3","isBolded":false,"associatedRows":["non - M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"57.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.0001","isBolded":false,"associatedRows":["non - M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"79.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"37.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"49.4","isBolded":false,"associatedRows":["+ rules","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"86.4","isBolded":false,"associatedRows":["M+DS"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"88.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"61.1","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.8","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"73.2","isBolded":false,"associatedRows":["M","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"26.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"45.9","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"21.4","isBolded":false,"associatedRows":["ICD","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"93.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"72.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"80.4","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.001","isBolded":false,"associatedRows":["non - M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"42.9%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"39.1","isBolded":false,"associatedRows":["ICD","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"73.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"47.3%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"85.9","isBolded":false,"associatedRows":["non - M","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"62.7","isBolded":false,"associatedRows":["M+DS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"63.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"100.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"50.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"73.7%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"64.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"45.7","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"47.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"58.3","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"91.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","P"],"associatedMergedColumns":["1 score in bold )"]},{"number":"81.0","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"39.2","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"27.3","isBolded":false,"associatedRows":["ICD","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","P","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"24.0","isBolded":false,"associatedRows":["ICD","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.5","isBolded":false,"associatedRows":["M"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"66.7","isBolded":false,"associatedRows":["+ rules","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"0.05","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"71.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"45.1%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"0.0005","isBolded":false,"associatedRows":["non - M","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"30.0","isBolded":false,"associatedRows":["ICD","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"96.5%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"22.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"83.8%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"60.0%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","F1"],"associatedMergedColumns":["1 score in bold )"]},{"number":"46.5","isBolded":false,"associatedRows":["GHNL API [ 21 ]","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 3","F1","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.6%","isBolded":false,"associatedRows":["non - M+DS","p \u003d","-","-","-"],"associatedColumns":["Table 7 F","l \u003d 4","R"],"associatedMergedColumns":["1 score in bold )"]},{"number":"66.7","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","p \u003d","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.5","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","p \u003d","-","-"],"associatedColumns":["Table 7 F","l \u003d 2","F1","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]}]},{"caption":"Table 2. \nBlueBERT-base (PubMed+MIMIC-III) was used to encode the text se-\nquences. \n\n","rows":["MedCAT [ 22 ]","+ rules","non - M+DS","GHNL API [ 21 ]","ICD","-","M","M+DS","+ WS ( rules+BERT )","+ SS ( anns+BERT )","ICD ? SemEHR+SS","non - M","SemEHR [ 15 ]","ICD ? SemEHR+WS"],"columns":["P","R","test","validation set ( n\u003d142+ / 400 )","Table 8 Comparison among encoding strategies for weakly","F1","test set ( n\u003d187+ / 673 )","( n\u003d30+ / 117 * 55 )","( n\u003d42+ / 192 * 82 )","validation"],"mergedAllColumns":["identification for MIMIC - III discharge summaries","summaries"],"numberCells":[{"number":"86.5","isBolded":false,"associatedRows":["M"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"63.4","isBolded":false,"associatedRows":["M","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"38.9","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"46.5","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"50.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"39.1","isBolded":false,"associatedRows":["ICD","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"72.7","isBolded":false,"associatedRows":["M+DS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.0","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"22.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"58.6","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.4","isBolded":true,"associatedRows":["non - M+DS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"95.2","isBolded":true,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"68.7","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"92.0","isBolded":true,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"26.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"87.3","isBolded":false,"associatedRows":["non - M","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"40.4","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"76.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"49.3","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.8","isBolded":true,"associatedRows":["non - M+DS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"15.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"85.7","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"85.9","isBolded":true,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"27.3","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"69.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"81.0","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"90.1","isBolded":true,"associatedRows":["non - M+DS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"55.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.4","isBolded":false,"associatedRows":["M+DS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"37.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"55.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"48.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.9","isBolded":false,"associatedRows":["non - M"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"66.7","isBolded":false,"associatedRows":["+ rules","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"69.4","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"30.0","isBolded":false,"associatedRows":["ICD","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.1","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"56.2","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"57.1","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"40.4","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"58.3","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"21.4","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"24.0","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"39.2","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.0","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"60.6","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"45.9","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"88.1","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"90.9","isBolded":false,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"85.8","isBolded":false,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"54.0","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"59.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"66.7","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"62.6","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"45.7","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"68.7","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"88.6","isBolded":false,"associatedRows":["non - M","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"81.3","isBolded":true,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"62.7","isBolded":false,"associatedRows":["M+DS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"54.8","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"49.4","isBolded":false,"associatedRows":["+ rules","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"73.2","isBolded":false,"associatedRows":["M","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"93.3","isBolded":true,"associatedRows":["SemEHR [ 15 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"80.4","isBolded":false,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"47.9","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.5","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"12.7","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]}]},{"caption":"Table 9 Micro-level results of admission-level rare disease \nidentification for MIMIC-III discharge summaries \n\nvalidation \n(n\u003d30+/117 * 55) \n\ntest \n(n\u003d42+/192 * 82) \nAdmission to ORDO \nP \nR \nF1 \nP \nR \nF1 \nGHNL API [21] \n45.7 \n70.0 \n55.3 \n40.4 \n54.8 \n46.5 \nMedCAT [22] \n47.9 \n76.7 \n59.0 \n37.7 \n69.0 \n48.7 \nSemEHR [15] \n15.4 \n93.3 \n26.4 \n12.7 \n95.2 \n22.3 \n+ rules \n39.2 \n66.7 \n49.4 \n38.9 \n88.1 \n54.0 \n+ WS (rules+BERT) \n57.1 \n66.7 \n61.5 \n49.3 \n78.6 \n60.6 \n+ SS (anns+BERT) \n-\n-\n-\n61.1 \n78.6 \n68.7 \nICD \n56.2 \n30.0 \n39.1 \n27.3 \n21.4 \n24.0 \nICD ? SemEHR+WS \n50.0 \n70.0 \n58.3 \n40.4 \n85.7 \n55.0 \nICD ? SemEHR+SS \n-\n-\n-\n45.9 \n81.0 \n58.6 \n","rows":["MedCAT [ 22 ]","+ rules","non - M+DS","GHNL API [ 21 ]","ICD","-","M","M+DS","+ WS ( rules+BERT )","+ SS ( anns+BERT )","ICD ? SemEHR+SS","non - M","SemEHR [ 15 ]","ICD ? SemEHR+WS"],"columns":["P","R","test","validation set ( n\u003d142+ / 400 )","Table 8 Comparison among encoding strategies for weakly","F1","test set ( n\u003d187+ / 673 )","( n\u003d30+ / 117 * 55 )","( n\u003d42+ / 192 * 82 )","validation"],"mergedAllColumns":["identification for MIMIC - III discharge summaries","summaries"],"numberCells":[{"number":"92.0","isBolded":true,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"86.4","isBolded":false,"associatedRows":["M+DS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"46.5","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"37.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"85.8","isBolded":false,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"50.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"90.1","isBolded":true,"associatedRows":["non - M+DS"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"48.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"55.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"78.0","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"93.3","isBolded":true,"associatedRows":["SemEHR [ 15 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"69.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"81.0","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"39.2","isBolded":false,"associatedRows":["+ rules"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"55.3","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"22.3","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"87.3","isBolded":false,"associatedRows":["non - M","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"85.7","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"27.3","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"66.7","isBolded":false,"associatedRows":["+ rules","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"54.0","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"40.4","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"15.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"88.6","isBolded":false,"associatedRows":["non - M","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"85.9","isBolded":true,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"88.1","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"80.4","isBolded":false,"associatedRows":["non - M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"39.1","isBolded":false,"associatedRows":["ICD","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"69.4","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"68.7","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.9","isBolded":false,"associatedRows":["non - M"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"81.3","isBolded":true,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"72.7","isBolded":false,"associatedRows":["M+DS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"60.6","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"40.4","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"66.7","isBolded":false,"associatedRows":["+ WS ( rules+BERT )","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.0","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"68.7","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"21.4","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"12.7","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.1","isBolded":true,"associatedRows":["+ SS ( anns+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.8","isBolded":true,"associatedRows":["non - M+DS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"26.4","isBolded":false,"associatedRows":["SemEHR [ 15 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"54.8","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"90.9","isBolded":false,"associatedRows":["non - M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"30.0","isBolded":false,"associatedRows":["ICD","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"62.7","isBolded":false,"associatedRows":["M+DS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"76.7","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"61.5","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"89.4","isBolded":true,"associatedRows":["non - M+DS","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"59.0","isBolded":false,"associatedRows":["MedCAT [ 22 ]","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"49.3","isBolded":true,"associatedRows":["+ WS ( rules+BERT )","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"63.4","isBolded":false,"associatedRows":["M","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R"],"associatedMergedColumns":["summaries"]},{"number":"45.9","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"86.5","isBolded":false,"associatedRows":["M"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P"],"associatedMergedColumns":["summaries"]},{"number":"78.6","isBolded":false,"associatedRows":["M","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P"],"associatedMergedColumns":["summaries"]},{"number":"58.3","isBolded":false,"associatedRows":["ICD ? SemEHR+WS","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"70.0","isBolded":false,"associatedRows":["GHNL API [ 21 ]","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1","validation","( n\u003d30+ / 117 * 55 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"49.4","isBolded":false,"associatedRows":["+ rules","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","P","validation","( n\u003d30+ / 117 * 55 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"57.1","isBolded":true,"associatedRows":["+ WS ( rules+BERT )"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"47.9","isBolded":false,"associatedRows":["MedCAT [ 22 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"24.0","isBolded":false,"associatedRows":["ICD","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"45.7","isBolded":false,"associatedRows":["GHNL API [ 21 ]"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"95.2","isBolded":true,"associatedRows":["SemEHR [ 15 ]","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R","test","( n\u003d42+ / 192 * 82 )","R"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"56.2","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","R","validation","( n\u003d30+ / 117 * 55 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"62.6","isBolded":false,"associatedRows":["M+DS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","R"],"associatedMergedColumns":["summaries"]},{"number":"58.6","isBolded":false,"associatedRows":["ICD ? SemEHR+SS","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","F1","test","( n\u003d42+ / 192 * 82 )","F1"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]},{"number":"73.2","isBolded":false,"associatedRows":["M","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","validation set ( n\u003d142+ / 400 )","F1"],"associatedMergedColumns":["summaries"]},{"number":"38.9","isBolded":false,"associatedRows":["+ rules","-","-","-"],"associatedColumns":["Table 8 Comparison among encoding strategies for weakly","test set ( n\u003d187+ / 673 )","P","test","( n\u003d42+ / 192 * 82 )","P"],"associatedMergedColumns":["identification for MIMIC - III discharge summaries"]}]},{"caption":"Table 10 Results on rare disease identification (Text-to-ORDO) for \nMIMIC-III and Tayside radiology reports \n\nMIMIC-III Radiology \n(n\u003d46+/198) \n\nTayside Brain Imaging \n(n\u003d42+/283) \nText to ORDO \nP \nR \nF1 \nP \nR \nF1 \nSemEHR \n22.9 \n93.5 \n36.8 \n13.1 \n78.6 \n22.4 \n+ WS (transfer) \n48.8 \n84.8 \n61.9 \n31.4 \n76.2 \n44.4 \n+ SS (transfer) \n86.5 \n69.6 \n77.1 \n53.2 \n59.5 \n56.2 \n+ rules (tuned) \n84.8 \n84.8 \n84.8 \n31.4 \n76.2 \n44.4 \n+ WS (in-domain) \n68.3 \n89.1 \n77.4 \n26.4 \n78.6 \n39.5 \n+ WS (+ tuning R) \n78.2 \n93.5 \n85.1 \n32.4 \n78.6 \n45.8 \n+ WS (+ tuning F1) \n86.7 \n84.8 \n85.7 \n46.3 \n73.8 \n56.9 \n\n","rows":["SemEHR","+ rules ( tuned )","+ SS ( transfer )","+ WS ( in - domain )","+ WS ( transfer )","+ WS ( + tuning R )","+ WS ( + tuning F1 )"],"columns":["P","R","( n\u003d42+ / 283 )","Table 10 Results on rare disease identification ( Text - to - ORDO ) for","F1","Tayside Brain Imaging","( n\u003d46+ / 198 )","MIMIC - III Radiology"],"mergedAllColumns":["MIMIC - III and Tayside radiology reports"],"numberCells":[{"number":"45.8","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"44.4","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"61.9","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"22.4","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"93.5","isBolded":true,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"46.3","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"48.8","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"22.9","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"69.6","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"32.4","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"76.2","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"89.1","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"73.8","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"84.8","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"26.4","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"85.1","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"59.5","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"13.1","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"78.6","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"84.8","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"93.5","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"76.2","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"36.8","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"86.7","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"78.2","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"78.6","isBolded":true,"associatedRows":["SemEHR"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"39.5","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"84.8","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"78.6","isBolded":true,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","R"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"84.8","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"56.2","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"53.2","isBolded":true,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"56.9","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"31.4","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"84.8","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"77.1","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"31.4","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"86.5","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"44.4","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","Tayside Brain Imaging","( n\u003d42+ / 283 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"68.3","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","P"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"77.4","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]},{"number":"85.7","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 10 Results on rare disease identification ( Text - to - ORDO ) for","MIMIC - III Radiology","( n\u003d46+ / 198 )","F1"],"associatedMergedColumns":["MIMIC - III and Tayside radiology reports"]}]},{"caption":"Table 11 Micro-level results of admission-level rare disease \nidentification for MIMIC-III and Tayside Radiology Reports \n\nMIMIC-III Radiology \n(n\u003d29+/145 * 43) \n\nTayside Brain Imaging \n(n\u003d41+/273 * 65) \nAdmission to ORDOs \nP \nR \nF1 \nP \nR \nF1 \nSemEHR \n19.4 \n93.1 \n32.1 \n12.8 \n78.0 \n22.0 \n+ WS (transfer) \n38.7 \n82.8 \n52.7 \n30.7 \n75.6 \n43.7 \n+ SS (transfer) \n83.3 \n69.0 \n75.5 \n53.2 \n61.0 \n56.8 \n+ rules (tuned) \n80.0 \n82.8 \n81.4 \n30.7 \n75.6 \n43.7 \n+ WS (in-domain) \n59.5 \n86.2 \n70.4 \n25.8 \n78.0 \n38.8 \n+ WS (+ tuning R) \n71.1 \n93.1 \n80.6 \n31.7 \n78.0 \n45.1 \n+ WS (+ tuning F1) \n82.8 \n82.8 \n82.8 \n46.3 \n75.6 \n57.4 \nICD \n46.4 \n44.8 \n45.6 \n-\n-\n-\nICD ? SemEHR+WS \n51.9 \n93.1 \n66.7 \n","rows":["SemEHR","+ rules ( tuned )","+ SS ( transfer )","+ WS ( in - domain )","+ WS ( transfer )","ICD","+ WS ( + tuning R )","+ WS ( + tuning F1 )","ICD ? SemEHR+WS"],"columns":["P","( n\u003d41+ / 273 * 65 )","R","F1","Tayside Brain Imaging","Table 11 Micro - level results of admission - level rare disease","( n\u003d29+ / 145 * 43 )","-","MIMIC - III Radiology"],"mergedAllColumns":["identification for MIMIC - III and Tayside Radiology Reports"],"numberCells":[{"number":"69.0","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"30.7","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"93.1","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"83.3","isBolded":true,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"46.3","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"75.6","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"80.0","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"53.2","isBolded":true,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"59.5","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"66.7","isBolded":false,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1","-"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"25.8","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"61.0","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"43.7","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"82.8","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"93.1","isBolded":true,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"57.4","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"82.8","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"82.8","isBolded":true,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"82.8","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"70.4","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"43.7","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"12.8","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"44.8","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"19.4","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"22.0","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"38.7","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"52.7","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"81.4","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"78.0","isBolded":true,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"51.9","isBolded":false,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P","-"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"93.1","isBolded":true,"associatedRows":["ICD ? SemEHR+WS"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R","-"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"45.6","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"75.6","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"38.8","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"75.6","isBolded":false,"associatedRows":["+ WS ( + tuning F1 )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"78.0","isBolded":true,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"32.1","isBolded":false,"associatedRows":["SemEHR"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"45.1","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"82.8","isBolded":false,"associatedRows":["+ WS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"80.6","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"86.2","isBolded":false,"associatedRows":["+ WS ( in - domain )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"56.8","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"30.7","isBolded":false,"associatedRows":["+ rules ( tuned )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"71.1","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"78.0","isBolded":true,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","R"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"75.5","isBolded":false,"associatedRows":["+ SS ( transfer )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","F1"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"46.4","isBolded":false,"associatedRows":["ICD"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","MIMIC - III Radiology","( n\u003d29+ / 145 * 43 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]},{"number":"31.7","isBolded":false,"associatedRows":["+ WS ( + tuning R )"],"associatedColumns":["Table 11 Micro - level results of admission - level rare disease","Tayside Brain Imaging","( n\u003d41+ / 273 * 65 )","P"],"associatedMergedColumns":["identification for MIMIC - III and Tayside Radiology Reports"]}]},{"caption":"Table 12 Examples of wrong and correct rare diseases identified by SemEHR with the weak supervised phenotype confirmation model \nfrom MIMIC-III discharge summaries \n\nROW ID \nDocument Structure \nText (with mention in bold) \nUMLS \nORDO \nPred Label Potential Reason \n26825 \npertinent results \n(should be pathol-\nogy) \n\nPathology: ...Immunostains for cytoker-\natin AE1/3 and CAM 5.2, CD-68, CD-\n79a, CD-138, S-100, LCA absorbed CEA, \nEMA, CD34, CD31, TTF-1, actin, desmin, \nMNF-116, calcitonin, and thyroglobulin \nare negative... \n\n","rows":["C0268596"],"columns":["scans have findings suggesting a propen -","Admission Medications","Gabapentin","sion )","acetaminophen ,","( should","daily ,","eyes . . .","History of Past Illness","Past Medical History : 1 . Diagnosed in","ically had bilateral uveitis significant with","drochlorothiazide / Triamterene","of","lial","Hy -","genase deficiency","8960","Nortriptyline","Hospital course","( EMA","Multiple","pertinent results","stable Hct . . .","acyl - CoA","-",". . . DFA for flu was negative ; urinary le -","RP bleed but was restarted after 48 hrs of","gionella antigen was also negative . . .","[ * * Doctor","sity to tracheobronchomalacia , as well","Migquin","869","his early years with bilateral uveitis , clin -","IMPRESSION : . . . Of note prior chest CT","loss of vision and sarcoid floaters in both","37 . 5mg / 25mg ,"],"mergedAllColumns":["as moderately severe emphysema . . . .","drops , Vitamin A palmitate 100 , 000 units","Prilosec prn","( negative test )","chorea . . ."],"numberCells":[{"number":"26351","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","869",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","8960","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . .","pertinent results","( should","sion )","Admission Medications","drochlorothiazide / Triamterene","37 . 5mg / 25mg ,","[ * * Doctor","Migquin","Gabapentin","acetaminophen ,"],"associatedMergedColumns":["Prilosec prn"]},{"number":"12659","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","869",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","8960","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . .","pertinent results","( should","sion )","Admission Medications","drochlorothiazide / Triamterene","37 . 5mg / 25mg ,","[ * * Doctor","Migquin","Gabapentin","acetaminophen ,","Hospital course","RP bleed but was restarted after 48 hrs of","stable Hct . . ."],"associatedMergedColumns":["Prilosec prn"]},{"number":"20984","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","869",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","8960","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . .","pertinent results","( should","sion )","Admission Medications","drochlorothiazide / Triamterene","37 . 5mg / 25mg ,","[ * * Doctor","Migquin","Gabapentin","acetaminophen ,","Hospital course","RP bleed but was restarted after 48 hrs of","stable Hct . . .","History of Past Illness","of"],"associatedMergedColumns":["chorea . . ."]},{"number":"48161","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","869",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","8960","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . .","pertinent results","( should","sion )"],"associatedMergedColumns":["as moderately severe emphysema . . . ."]},{"number":"46361","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","869",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","8960","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . ."],"associatedMergedColumns":["( negative test )"]},{"number":"26791","isBolded":false,"associatedRows":["C0268596"],"associatedColumns":[],"associatedMergedColumns":[]},{"number":"1.5tabletsdialyforretinitispigmentosa,","isBolded":false,"associatedRows":[],"associatedColumns":["Multiple","acyl - CoA","genase deficiency","( EMA","lial","-",". . . DFA for flu was negative ; urinary le -","gionella antigen was also negative . . .","Past Medical History : 1 . Diagnosed in","his early years with bilateral uveitis , clin -","ically had bilateral uveitis significant with","loss of vision and sarcoid floaters in both","eyes . . .","IMPRESSION : . . . Of note prior chest CT","scans have findings suggesting a propen -","sity to tracheobronchomalacia , as well","Hy -","drochlorothiazide / Triamterene","daily ,","daily ,","daily ,","Nortriptyline"],"associatedMergedColumns":["drops , Vitamin A palmitate 100 , 000 units"]}]}]